Evidence map›Paper›PMID 25798239›Full record

ArticleBiomedical reports2015

Mechanism of alternative splicing and its regulation.

Yan Wang, Jing Liu, B O Huang, Yan-Mei Xu, Jing Li, Lin-Feng Huang, Jin Lin, Jing Zhang, Qing-Hua Min, Wei-Ming Yang and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Biomedical reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 256 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
256citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

256 citing papers in PubMed, 1 synthesis or guideline pooled it, 495 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Allele-specific methylation, and InDels ofHorticulture research · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. From development to disease: the neuronal role of hnRNPs through the lens ofFrontiers in cell and developmental biology · 2026
    Review
  19. Article
  20. Review

196 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yan WangDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Jing LiuDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
B O HuangDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Yan-Mei XuDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Jing LiDepartment of Clinical Laboratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Lin-Feng HuangDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Jin LinDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Jing ZhangDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Qing-Hua MinDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Wei-Ming YangDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Xiao-Zhong WangDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, P.R. China.
Nanchang University · CNSecond Affiliated Hospital of Nanchang University · CNFirst Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternative splicing of precursor mRNA is an essential mechanism to increase the complexity of gene expression, and it plays an important role in cellular differentiation and organism development. Regulation of alternative splicing is a complicated process in which numerous interacting components are at work, including cis-acting elements and trans-acting factors, and is further guided by the functional coupling between transcription and splicing. Additional molecular features, such as chromatin structure, RNA structure and alternative transcription initiation or alternative transcription termination, collaborate with these basic components to generate the protein diversity due to alternative splicing. All these factors contributing to this one fundamental biological process add up to a mechanism that is critical to the proper functioning of cells. Any corruption of the process may lead to disruption of normal cellular function and the eventuality of disease. Cancer is one of those diseases, where alternative splicing may be the basis for the identification of novel diagnostic and prognostic biomarkers, as well as new strategies for therapy. Thus, an in-depth understanding of alternative splicing regulation has the potential not only to elucidate fundamental biological principles, but to provide solutions for various diseases.

Indexed as

alternative splicingdiseasemechanismprecursor mRNAregulation

Identifiers

PMID25798239
PMCPMC4360811
OpenAlexW2018608365

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.